GE Ventures and Mayo Clinic have jointly set up a new company to scale and digitise cell and gene therapies.

Known as Vitruvian Networks, the new company will focus on combating cancer and other diseases through advanced software systems and manufacturing services that will expedite patient access to personalised therapies.

Using Mayo Clinic’s data related to biomarkers, cell therapy processes and clinical outcomes, Vitruvian Networks will carry out the development of personalised therapies.

A team of hybrid of life science and software development experts at Vitruvian Networks will initially focus on the production of autologous cell therapies that target blood cancers.

“Mayo Clinic is a key leader within patient treatment delivery in cancer care and regenerative medicine, so we are honoured to have incubated this solution in joint partnership.”

Autologous therapies in the area of regenerative and personalised medicine have shown promising results in treating life-threatening diseases.

GE Ventures CEO Sue Siegel said: “Merging GE’s operational excellence with emerging cell and gene therapies will enable faster, more effective and safer treatments for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Mayo Clinic is a key leader within patient treatment delivery in cancer care and regenerative medicine, so we are honoured to have incubated this solution in joint partnership.”

The new company will also develop the supporting standards, infrastructure and ecosystem that will protect patients and expedite discovery, delivery and regulation in the field.

It will use tools from GE Healthcare‘s cell therapy business in addition to those of other leading partners.

Vitruvian Networks will also have access to the GE Store to repurpose analytical capabilities and manufacturing process excellence from business units, such as GE Healthcare, GE Aviation and GE Power.